Estimation of the global prevalence of dementia. In 2019 and forecasted prevalence in 2050: an analysis for the global burden of Disease Study 2019. Lancet Public Health. 2022;7(2):e105–25.

Article  Google Scholar 

Lane CA, Hardy J, Schott JM. Alzheimer’s disease. Eur J Neurol. 2018;25(1):59–70.

Article  CAS  PubMed  Google Scholar 

Jia L, Quan M, Fu Y, Zhao T, Li Y, Wei C, et al. Dementia in China: epidemiology, clinical management, and research advances. Lancet Neurol. 2020;19(1):81–92.

Article  PubMed  Google Scholar 

Global regional, national burden of neurological disorders. 1990–2016: a systematic analysis for the global burden of Disease Study 2016. Lancet Neurol. 2019;18(5):459–80.

Article  Google Scholar 

Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, et al. National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach. Acta Neuropathol. 2012;123(1):1–11.

Article  CAS  PubMed  Google Scholar 

Thal DR, Walter J, Saido TC, Fändrich M. Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer’s disease. Acta Neuropathol. 2015;129(2):167–82.

Article  CAS  PubMed  Google Scholar 

Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, et al. Alzheimer’s disease. Lancet. 2021;397(10284):1577–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aisen PS, Cummings J, Jack CR Jr., Morris JC, Sperling R, Frölich L, et al. On the path to 2025: understanding the Alzheimer’s disease continuum. Alzheimers Res Ther. 2017;9(1):60.

Article  PubMed  PubMed Central  Google Scholar 

Nabers A, Perna L, Lange J, Mons U, Schartner J, Güldenhaupt J et al. Amyloid blood biomarker detects Alzheimer’s disease. EMBO Mol Med. 2018;10(5).

Jack CR Jr., Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA Research Framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 2018;14(4):535–62.

Article  PubMed  Google Scholar 

Roe CM, Fagan AM, Grant EA, Hassenstab J, Moulder KL, Maue Dreyfus D, et al. Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later. Neurology. 2013;80(19):1784–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Soldan A, Pettigrew C, Cai Q, Wang MC, Moghekar AR, O’Brien RJ, et al. Hypothetical preclinical Alzheimer Disease groups and Longitudinal Cognitive Change. JAMA Neurol. 2016;73(6):698–705.

Article  PubMed  PubMed Central  Google Scholar 

Dominguez LJ, Veronese N, Vernuccio L, Catanese G, Inzerillo F, Salemi G et al. Nutrition, Physical Activity, and other Lifestyle factors in the Prevention of Cognitive decline and Dementia. Nutrients. 2021;13(11).

Campbell NL, Unverzagt F, LaMantia MA, Khan BA, Boustani MA. Risk factors for the progression of mild cognitive impairment to dementia. Clin Geriatr Med. 2013;29(4):873–93.

Article  PubMed  PubMed Central  Google Scholar 

Crous-Bou M, Minguillón C, Gramunt N, Molinuevo JL. Alzheimer’s disease prevention: from risk factors to early intervention. Alzheimers Res Ther. 2017;9(1):71.

Article  PubMed  PubMed Central  Google Scholar 

Xu W, Tan L, Wang HF, Jiang T, Tan MS, Tan L, et al. Meta-analysis of modifiable risk factors for Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2015;86(12):1299–306.

PubMed  Google Scholar 

Ge T, Sabuncu MR, Smoller JW, Sperling RA, Mormino EC. Dissociable influences of APOE ε4 and polygenic risk of AD dementia on amyloid and cognition. Neurology. 2018;90(18):e1605–12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chau E, Kim JR. α-synuclein-assisted oligomerization of β-amyloid (1–42). Arch Biochem Biophys. 2022;717:109120.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aisen PS, Petersen RC, Donohue MC, Gamst A, Raman R, Thomas RG, et al. Clinical core of the Alzheimer’s Disease Neuroimaging Initiative: progress and plans. Alzheimers Dement. 2010;6(3):239–46.

Article  PubMed  Google Scholar 

Shaw LM, Vanderstichele H, Knapik-Czajka M, Clark CM, Aisen PS, Petersen RC, et al. Cerebrospinal fluid biomarker signature in Alzheimer’s disease neuroimaging initiative subjects. Ann Neurol. 2009;65(4):403–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Elman JA, Panizzon MS, Gustavson DE, Franz CE, Sanderson-Cimino ME, Lyons MJ, et al. Amyloid-β positivity predicts cognitive decline but Cognition predicts progression to Amyloid-β positivity. Biol Psychiatry. 2020;87(9):819–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Landau SM, Breault C, Joshi AD, Pontecorvo M, Mathis CA, Jagust WJ, et al. Amyloid-β imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods. J Nucl Med. 2013;54(1):70–7.

Article  CAS  PubMed  Google Scholar 

Araque Caballero M, Brendel M, Delker A, Ren J, Rominger A, Bartenstein P, et al. Mapping 3-year changes in gray matter and metabolism in Aβ-positive nondemented subjects. Neurobiol Aging. 2015;36(11):2913–24.

Article  CAS  PubMed  Google Scholar 

Silva MVF, Loures CMG, Alves LCV, de Souza LC, Borges KBG, Carvalho MDG. Alzheimer’s disease: risk factors and potentially protective measures. J Biomed Sci. 2019;26(1):33.

Article  PubMed  PubMed Central  Google Scholar 

Meyer PF, Pichet Binette A, Gonneaud J, Breitner JCS, Villeneuve S. Characterization of Alzheimer Disease Biomarker discrepancies using Cerebrospinal Fluid Phosphorylated Tau and AV1451 Positron Emission Tomography. JAMA Neurol. 2020;77(4):508–16.

Article  PubMed  PubMed Central  Google Scholar 

Dodge HH, Zhu J, Harvey D, Saito N, Silbert LC, Kaye JA, et al. Biomarker progressions explain higher variability in stage-specific cognitive decline than baseline values in Alzheimer disease. Alzheimers Dement. 2014;10(6):690–703.

Article  PubMed  Google Scholar 

Gibbons LE, Carle AC, Mackin RS, Harvey D, Mukherjee S, Insel P, et al. A composite score for executive functioning, validated in Alzheimer’s Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment. Brain Imaging Behav. 2012;6(4):517–27.

Article  PubMed  PubMed Central  Google Scholar 

Crane PK, Carle A, Gibbons LE, Insel P, Mackin RS, Gross A, et al. Development and assessment of a composite score for memory in the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Brain Imaging Behav. 2012;6(4):502–16.

Article  PubMed  PubMed Central  Google Scholar 

Molgaard CA. Multivariate analysis of Hachinski’s scale for discriminating senile dementia of the Alzheimer’s type from multiinfarct dementia. Neuroepidemiology. 1987;6(3):153–60.

Article  CAS  PubMed  Google Scholar 

Lebedeva A, Westman E, Lebedev AV, Li X, Winblad B, Simmons A, et al. Structural brain changes associated with depressive symptoms in the elderly with Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2014;85(8):930–5.

Article  PubMed  Google Scholar 

Wen C, Hu H, Ou YN, Bi YL, Ma YH, Tan L, et al. Risk factors for subjective cognitive decline: the CABLE study. Transl Psychiatry. 2021;11(1):576.

Article  PubMed  PubMed Central  Google Scholar 

Bürger née Buch K, Padberg F, Nolde T, Teipel SJ, Stübner S, Haslinger A, et al. Cerebrospinal fluid tau protein shows a better discrimination in young old (< 70 years) than in old old patients with Alzheimer’s disease compared with controls. Neurosci Lett. 1999;277(1):21–4.

Article  PubMed  Google Scholar